1996
DOI: 10.1172/jci118592
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.

Abstract: Clearance of the hepatitis B virus (HBV) during acute hepatitis is associated with a strong, polyclonal, multispecific cytotoxic T lymphocyte (CTL) response to the viral envelope, nucleocapsid and polymerase proteins that persists for decades after clinical recovery. In contrast, chronically infected patients usually fail to mount a strong CTL response to this virus. In this study we demonstrate that chronically infected patients who experience a spontaneous or interferon-induced remission develop a CTL respon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
203
0
4

Year Published

1997
1997
2006
2006

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 289 publications
(217 citation statements)
references
References 30 publications
10
203
0
4
Order By: Relevance
“…1 Thus, control of HBV infection is associated with a multispecific and polyclonal cytotoxic T-cell response and a strong type 1 T helper cell response. 2,3 In contrast, chronically infected patients display oligoclonal T helper cell responses with weak or undetectable cytotoxic T-cell activity. 4 Dendritic cells (DC) are the most important professional antigen-presenting cells.…”
Section: H Epatitis B Virus (Hbv) Infection Represents Amentioning
confidence: 99%
“…1 Thus, control of HBV infection is associated with a multispecific and polyclonal cytotoxic T-cell response and a strong type 1 T helper cell response. 2,3 In contrast, chronically infected patients display oligoclonal T helper cell responses with weak or undetectable cytotoxic T-cell activity. 4 Dendritic cells (DC) are the most important professional antigen-presenting cells.…”
Section: H Epatitis B Virus (Hbv) Infection Represents Amentioning
confidence: 99%
“…41 Consider, also, that there are approximately 10 12 lymphocytes in the entire body and that the HBV-specific CTL precursor frequency at the height of the CTL response in a strongly reactive patient with acute hepatitis is rarely greater than 10 Ϫ4 ; usually it is much lower. 42 Hence, there should be no more than 10 8 HBV-specific CTL in the entire body at any point in time. Therefore, if every HBV-specific CTL in the entire body were to enter the liver at the same time (highly unlikely), and if most of the hepatocytes were infected (very common), there would be 1 specific CTL in the liver for every 1000 infected hepatocytes.…”
Section: Viral Clearance By Destruction Of Infected Cellsmentioning
confidence: 99%
“…This type of CTL response is unusual, however, during HBV infection, when the CTL response is typically vigorous and multispecific during acute hepatitis and weak or undetectable during chronic hepatitis. 42,65,66,72 Accordingly, mutational inactivation of CTL epitopes is extremely uncommon during chronic HBV infection. 73 Nonetheless, strong, narrowly focused CTL responses do occur occasionally in these patients, 20 and in this setting viral escape mutations can occur.…”
Section: Mechanisms Of Hbv Persistencementioning
confidence: 99%
“…In acutely infected patients the immune response includes high Ab titers against the core and the envelope proteins as well as vigorous, polyclonal, and multispecific cellular responses (3). On the other hand, in patients who do not clear the viral infection or who were infected early in life and become chronic carriers, the cellular response is undetectable or weak and is restricted to few antigenic determinants (4). Several observations suggest that cytotoxic T cells are required for the viral clearance, although lysis of infected hepatocytes is unlikely to be the only mechanism through which CD8 ϩ T cells exert their anti-viral effect.…”
Section: H Epatitis B Virus (Hbv)mentioning
confidence: 99%
“…RBC-depleted splenocytes (0.83% NH 4 Cl, 5 min, on ice) were cultured (5 ϫ 10 6 cells in 24-well plates) in ␣-MEM (Life Technologies) supplemented with 10 mM HEPES, nonessential amino acids, 1 mM sodium pyruvate, 5 ϫ 10 Ϫ5 M 2-ME, antibiotics, and 10% FCS (Myoclone, Life Technologies). These cells were stimulated for 6 -7 days with peptide-loaded LPS-blast cells as APCs at an effector-presenting cell ratio of 2:1 to 1:1.…”
Section: Measurement Of Ctl Activitymentioning
confidence: 99%